Using bone densitometry to monitor therapy in treating osteoporosis: pros and cons.

被引:10
|
作者
Deal C.L. [1 ]
机构
[1] Center for Osteoporosis and Metabolic Disease, The Cleveland Clinic Foundation
[2] Immunologic Diseases, Desk A-50, 9500 Euclid Avenue, Cleveland, 44195, OH
关键词
Vertebral Fracture; Alendronate; Raloxifene; Risedronate; Bone Densitometry;
D O I
10.1007/s11926-001-0023-4
中图分类号
学科分类号
摘要
Measurement of bone density is crucial for evaluating fracture risk. Low bone mass is a powerful predictor of fracture and is necessary to assess the need for treatment. Dual energy x-ray absorptiometry is accurate and precise. Use of bone density for monitoring therapy is an important tool for evaluating response to therapy, but an understanding of the limitations of the procedure are important for the practicing physician. Precision error of the technology and what change in density is clinically significant (least significant change) are important concepts to interpret results and make appropriate treatment decisions. This article reviews the use of bone densitometry as a tool for monitoring treatment in patients with low bone mass.
引用
收藏
页码:233 / 239
页数:6
相关论文
共 50 条
  • [21] Osteoporosis therapy following bone densitometry - Patient expectations as determinants of drug initiation and persistence
    Brask-Rasmussen, Dorthe
    Cadarette, Suzanne M.
    Eskildsen, Peter C.
    Abrahamsen, Bo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S59 - S60
  • [22] Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons
    Nathan, Steven D.
    Wanger, Jack
    Zibrak, Joseph D.
    Wencel, Mark L.
    Burg, Cindy
    Stauffer, John L.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (02) : 175 - 181
  • [23] Osteoporosis Prediction Using Machine-Learned Optical Bone Densitometry Data
    Miura, Kaname
    Tanaka, Shigeo M.
    Chotipanich, Chanisa
    Chobpenthai, Thanapon
    Jantarato, Attapon
    Khantachawana, Anak
    ANNALS OF BIOMEDICAL ENGINEERING, 2024, 52 (02) : 396 - 405
  • [24] Osteoporosis Prediction Using Machine-Learned Optical Bone Densitometry Data
    Kaname Miura
    Shigeo M. Tanaka
    Chanisa Chotipanich
    Thanapon Chobpenthai
    Attapon Jantarato
    Anak Khantachawana
    Annals of Biomedical Engineering, 2024, 52 : 396 - 405
  • [25] Forearm Bone Mineral Densitometry Cannot be Used to Monitor Response to Alendronate Therapy in Postmenopausal Women
    M. L. Bouxsein
    R. A. Parker
    S. L. Greenspan
    Osteoporosis International, 1999, 10 : 505 - 509
  • [26] Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women
    Bouxsein, ML
    Parker, RA
    Greenspan, SL
    OSTEOPOROSIS INTERNATIONAL, 1999, 10 (06) : 505 - 509
  • [27] Osteoporosis Therapy following Bone Densitometry - Patient Expectations as Determinants of Drug Initiation and Persistence.
    Brask-Rasmussen, D.
    Cadarette, S. M.
    Eskildsen, P.
    Abrahamsen, B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S468 - S468
  • [28] A prospective study of discordance in diagnosis of osteoporosis using spine and proximal femur bone densitometry
    D. O'Gradaigh
    I. Debiram
    S. Love
    H.K. Richards
    J.E. Compston
    Osteoporosis International, 2003, 14 : 13 - 18
  • [29] Prevalence and risk factors of discordance in diagnosis of osteoporosis using spine and hip bone densitometry
    El Maghraoui, A.
    Abayi, D. A. Mouinga
    Mounach, A.
    Ghozani, I.
    Nouijai, A.
    Ghazi, M.
    Achemlal, L.
    Bezza, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 524 - 524
  • [30] Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry
    Desouki, MI
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S122 - S122